Changchun Hi-Tech announced that the company's holding subsidiary, Jilin Huakang Pharmaceutical Co., Ltd., was newly included in the “National Essential Drug Catalogue”, which will take effect on September 1, 2026. This product is used for acute pyelonephritis, etc., and has effects such as clearing heat and detoxifying. This inclusion will have a positive effect on subsequent market coverage and sales of products, but the impact on the company's operating performance cannot be estimated yet, and it will not have a significant impact on performance in the short term.

Changchun Hi-Tech announced that the company's holding subsidiary, Jilin Huakang Pharmaceutical Co., Ltd., was newly included in the “National Essential Drug Catalogue”, which will take effect on September 1, 2026. This product is used for acute pyelonephritis, etc., and has effects such as clearing heat and detoxifying. This inclusion will have a positive effect on subsequent market coverage and sales of products, but the impact on the company's operating performance cannot be estimated yet, and it will not have a significant impact on performance in the short term.